Mirum Pharmaceuticals Quote - MIRM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

44.28

Bid

42.98

Ask

45.51

Volume

392,599

43.84 Day's Range 45.90

23.14 52 Week Range 54.234

Market Cap

2.17B

Previous Close

44.56

Open

44.77

Last Trade

44.28

Last Trade Time

Financial Volume

US$ 17,574,746

VWAP

44.7651

Average Volume (3m)

520,024

Shares Outstanding

49,014,190

Dividend Yield

PE Ratio

-24.66

Earnings Per Share (EPS)

-1.79

Revenue

336.89M

Net Profit

-87.94M

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC... Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Headquarters

Dover, Delaware, USA

Founded

Mirum Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MIRM. The last closing price for Mirum Pharmaceuticals was US$44.56. Over the last year, Mirum Pharmaceuticals shares have traded in a share price range of US$ 23.14 to US$ 54.234.

Mirum Pharmaceuticals currently has 49,014,190 shares outstanding. The market capitalization of Mirum Pharmaceuticals is US$2.18 billion. Mirum Pharmaceuticals has a price to earnings ratio (PE ratio) of -24.66.

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update

- 2024 net product sales of $336.4 million - 2025 expected global net product sales of $420 million to $435 million - VISTAS study of volixibat...

Mirum’s CTEXLI™ (chenodiol) Tablets Receives FDA Approval for Treatment of Cerebrotendinous Xanthomatosis (CTX)

CTEXLI is the first and only medication approved for the treatment of CTX in adults Approval based on Phase 3 RESTORE study results CTEXLI...

Mirum Pharmaceuticals to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call on February 26, 2025

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that it will report fourth quarter and year-end 2024 financial results on Wednesday...

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that on February 10, 2025, the Compensation Committee of Mirum’s Board of Directors...

Form 4 - Statement of changes in beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.42	0.957592339261	43.86	46.02	42.01	530585	44.02032556	CS
4	-6.74	-13.210505684	51.02	54.234	42.01	604228	47.88025759	CS
12	3.7	9.11779201577	40.58	54.234	40.55	520024	47.01528006	CS
26	2.8	6.75024108004	41.48	54.234	36.8591	446053	44.26080338	CS
52	14.49	48.6404833837	29.79	54.234	23.14	524455	37.31912228	CS
156	22.53	103.586206897	21.75	54.234	17.315	465825	30.18493465	CS
260	31.61	249.486977111	12.67	54.234	9.14	329833	28.32159927	CS

MIRM - Frequently Asked Questions (FAQ)

What is the current Mirum Pharmaceuticals share price?

The current share price of Mirum Pharmaceuticals is US$ 44.28

How many Mirum Pharmaceuticals shares are in issue?

Mirum Pharmaceuticals has 49,014,190 shares in issue

What is the market cap of Mirum Pharmaceuticals?

The market capitalisation of Mirum Pharmaceuticals is USD 2.18B

What is the 1 year trading range for Mirum Pharmaceuticals share price?

Mirum Pharmaceuticals has traded in the range of US$ 23.14 to US$ 54.234 during the past year

What is the PE ratio of Mirum Pharmaceuticals?

The price to earnings ratio of Mirum Pharmaceuticals is -24.66

What is the cash to sales ratio of Mirum Pharmaceuticals?

The cash to sales ratio of Mirum Pharmaceuticals is 6.44

What is the reporting currency for Mirum Pharmaceuticals?

Mirum Pharmaceuticals reports financial results in USD

What is the latest annual turnover for Mirum Pharmaceuticals?

The latest annual turnover of Mirum Pharmaceuticals is USD 336.89M

What is the latest annual profit for Mirum Pharmaceuticals?

The latest annual profit of Mirum Pharmaceuticals is USD -87.94M

What is the registered address of Mirum Pharmaceuticals?

The registered address for Mirum Pharmaceuticals is 838 WALKER ROAD, SUITE 21-2, DOVER, DELAWARE, 19904

Which industry sector does Mirum Pharmaceuticals operate in?

Mirum Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
RDUSRadius Recycling Inc	US$ 27.902 (104.26%)	8.53M
BONBon Natural Life Ltd	US$ 1.40 (90.29%)	84M
SUNESUNation Energy Inc	US$ 0.5213 (62.96%)	513.96M
WHLRLWheeler Real Estate Investment Trust Inc	US$ 255.00 (39.80%)	222
AAOIApplied Optoelectronics Inc	US$ 22.105 (39.29%)	17.01M
GLSTUGlobal Star Acquisition Inc	US$ 2.00 (-69.23%)	421
CURRCurrenc Group Inc	US$ 2.03 (-41.33%)	1.42M
ADTXAditxt Inc	US$ 0.0201 (-39.82%)	240.2M
HEPAHepion Pharmaceuticals Inc	US$ 0.0228 (-39.68%)	161.52M
WKSPWorksport Ltd	US$ 0.36205 (-35.45%)	4.96M
SUNESUNation Energy Inc	US$ 0.5213 (62.96%)	513.96M
NVDANVIDIA Corporation	US$ 121.67 (5.27%)	277.56M
ADTXAditxt Inc	US$ 0.0201 (-39.82%)	240.2M
HEPAHepion Pharmaceuticals Inc	US$ 0.0228 (-39.68%)	161.52M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 9.225 (7.64%)	160.21M